Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hui-Min Biotech is a diversified life sciences company based in Taiwan that specializes in the development and manufacture of pharmaceuticals, health supplements, and medical devices. Founded in 1998, the company operates a robust pharmaceutical division that produces a wide range of generic drugs focusing on gastrointestinal, respiratory, and cardiovascular health. In addition to its core pharmaceutical business, Hui-Min Biotech is a leader in the research and production of functional probiotics and nutritional supplements aimed at improving metabolic and digestive health. The company maintains high-standard manufacturing facilities and distributes its products across Asian markets. Hui-Min Biotech also engages in R&D for proprietary formulations and new drug applications in the fields of hepatology and gastroenterology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huimin.